← Back to Analyst Consensus 
TOI Buy
Starling Oncology, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 9, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 6, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Jun 17, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jun 8, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Mar 13, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Mar 13, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Mar 9, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Mar 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Nov 25, 2025 | Needham | initiate | — → Buy | $5 | 50% |
| Oct 21, 2025 | BTIG | reiterate | Buy → Buy | $7 | 52% |
| Jul 16, 2025 | B. Riley Securities | initiate | — → Buy | $6 | 55% |
| Jun 16, 2023 | Guggenheim | maintain | — → Buy | $2 | 52% |
| Mar 20, 2023 | Guggenheim | maintain | — → Neutral | $3 | 52% |
| Nov 11, 2022 | Guggenheim | maintain | — → Buy | $6 | 52% |
| Aug 15, 2022 | Jefferies | initiate | — → Buy | $10 | 52% |
Price Target Trend
Mar 30, 2026 Latest: $8.4 Oct 2, 2026
EPS Estimates
+1q $-0.04
Lo: $-0.06 Hi: $0.00
5 analysts 0q $-0.06
Lo: $-0.07 Hi: $-0.06
5 analysts ▲1
+1y $-0.03
Lo: $-0.12 Hi: $0.14
4 analysts ▲1
0y $-0.14
Lo: $-0.18 Hi: $-0.09
5 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days